| Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells Y Gao, F Souza-Fonseca-Guimaraes, T Bald, SS Ng, A Young, SF Ngiow, ... Nature immunology 18 (9), 1004-1015, 2017 | 574 | 2017 |
| Myeloid immunosuppression and immune checkpoints in the tumor microenvironment K Nakamura, MJ Smyth Cellular & molecular immunology 17 (1), 1-12, 2020 | 343 | 2020 |
| TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma C Guillerey, H Harjunpää, N Carrié, S Kassem, T Teo, K Miles, ... Blood, The Journal of the American Society of Hematology 132 (16), 1689-1694, 2018 | 268 | 2018 |
| Effect of silica particle size on macrophage inflammatory responses T Kusaka, M Nakayama, K Nakamura, M Ishimiya, E Furusawa, ... PloS one 9 (3), e92634, 2014 | 251 | 2014 |
| Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy N Glodde, T Bald, D van den Boorn-Konijnenberg, K Nakamura, ... Immunity 47 (4), 789-802. e9, 2017 | 250 | 2017 |
| Targeting CD39 in cancer reveals an extracellular ATP-and inflammasome-driven tumor immunity XY Li, AK Moesta, C Xiao, K Nakamura, M Casey, H Zhang, J Madore, ... Cancer discovery 9 (12), 1754-1773, 2019 | 216 | 2019 |
| Dysregulated IL-18 is a key driver of immunosuppression and a possible therapeutic target in the multiple myeloma microenvironment K Nakamura, S Kassem, A Cleynen, ML Chretien, C Guillerey, EM Putz, ... Cancer cell 33 (4), 634-648. e5, 2018 | 195 | 2018 |
| Targeting cancer‐related inflammation in the era of immunotherapy K Nakamura, MJ Smyth Immunology and cell biology 95 (4), 325-332, 2017 | 176 | 2017 |
| The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation SS Ng, F De Labastida Rivera, J Yan, D Corvino, I Das, P Zhang, R Kuns, ... Nature immunology 21 (10), 1205-1218, 2020 | 137 | 2020 |
| Cancer immunoediting and immune dysregulation in multiple myeloma K Nakamura, MJ Smyth, L Martinet Blood, The Journal of the American Society of Hematology 136 (24), 2731-2740, 2020 | 130 | 2020 |
| Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies C Guillerey, K Nakamura, S Vuckovic, GR Hill, MJ Smyth Cellular and Molecular Life Sciences 73, 1569-1589, 2016 | 127 | 2016 |
| CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in CD8+ T cells M Braun, AR Aguilera, A Sundarrajan, D Corvino, K Stannard, S Krumeich, ... Immunity 53 (4), 805-823. e15, 2020 | 108 | 2020 |
| Targeting immune checkpoints in hematological malignancies B Salik, MJ Smyth, K Nakamura Journal of hematology & oncology 13 (1), 111, 2020 | 98 | 2020 |
| Activation of the NLRP3 inflammasome by cellular labile iron K Nakamura, T Kawakami, N Yamamoto, M Tomizawa, T Fujiwara, T Ishii, ... Experimental hematology 44 (2), 116-124, 2016 | 80 | 2016 |
| Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand K Nakamura, M Nakayama, M Kawano, R Amagai, T Ishii, H Harigae, ... Proceedings of the National Academy of Sciences 110 (23), 9421-9426, 2013 | 71 | 2013 |
| Inhibitory receptor paired Ig-like receptor B is exploited by Staphylococcus aureus for virulence M Nakayama, K Kurokawa, K Nakamura, BL Lee, K Sekimizu, ... The Journal of Immunology 189 (12), 5903-5911, 2012 | 64 | 2012 |
| Anticancer activity of a Gold (I) phosphine thioredoxin reductase inhibitor in multiple myeloma JH Sze, PV Raninga, K Nakamura, M Casey, KK Khanna, ... Redox Biology 28, 101310, 2020 | 48 | 2020 |
| TREM2 marks tumor-associated macrophages K Nakamura, MJ Smyth Signal Transduction and Targeted Therapy 5 (1), 233, 2020 | 38 | 2020 |
| Ulcerative colitis is not a rare complication of Takayasu arteritis R Watanabe, T Ishii, K Nakamura, T Shirai, H Fujii, S Saito, H Harigae Modern Rheumatology 24 (2), 372-373, 2014 | 38 | 2014 |
| Targeting an adenosine-mediated “don’t eat me signal” augments anti-lymphoma immunity by anti-CD20 monoclonal antibody K Nakamura, M Casey, H Oey, F Vari, J Stagg, MK Gandhi, MJ Smyth Leukemia 34 (10), 2708-2721, 2020 | 36 | 2020 |
